Cargando…
Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial
BACKGROUND: Remimazolam is a novel intravenous benzodiazepine that is appropriate for the maintenance of anesthesia. Quality of recovery is an important component of health care quality, but there is no published randomized control trial focused on the quality of recovery in patients undergoing tota...
Autores principales: | Song, Seung Woo, Jang, Yo Nam, Yoon, Min-Woo, Jeon, Yeong-Gwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288018/ https://www.ncbi.nlm.nih.gov/pubmed/35842575 http://dx.doi.org/10.1186/s12871-022-01770-x |
Ejemplares similares
-
Post-induction hypotension with remimazolam versus propofol in patients routinely administered angiotensin axis blockades: a randomized control trial
por: Song, Seung Woo, et al.
Publicado: (2023) -
Comparison of Core Body Temperatures in Patients Administered Remimazolam or Propofol during Robotic-Assisted and Laparoscopic Radical Prostatectomy
por: Lee, Cheol, et al.
Publicado: (2022) -
Postoperative Heart Failure with Preserved Ejection Fraction Induced by Flumazenil Administered for Remimazolam Antagonism
por: Koh, Keito, et al.
Publicado: (2022) -
Comparison of the recovery profile of remimazolam with flumazenil and propofol anesthesia for open thyroidectomy
por: Lee, Ho-Jin, et al.
Publicado: (2023) -
Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia
por: Lohmer, Lauren L., et al.
Publicado: (2020)